Cover Image

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial

Co-administration of vaccines can facilitate the introduction of new vaccines in immunization schedules. This study aimed to evaluate the immunogenicity and safety of co-administration with live attenuated varicella vaccine (VarV) and inactivated hepatitis A vaccine (HepA) among children aged 12 ~ 1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dapeng Sun (Author), Dan Yu (Author), Zhenhua Du (Author), Ningning Jia (Author), Xiaodong Liu (Author), Jianwen Sun (Author), Qing Xu (Author), Zhuoqun Sun (Author), Chunfang Luan (Author), Jingjing Lv (Author), Ping Xiong (Author), Li Zhang (Author), Xueyan Sha (Author), Yongjun Gao (Author), Dianmin Kang (Author)
Format:	Book
Published:	Taylor & Francis Group, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial
by: Yajun Shu, et al.
Published: (2024)

Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines
by: Priya Pereira, et al.
Published: (2020)

Varicella Vaccine
by: Patrick Duff
Published: (1996)

Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination：a meta-analysis
by: Mingjuan Yin, et al.
Published: (2018)

Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review
by: Jessica Leung, et al.
Published: (2017)

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial
by: Ahmet Omma, et al.
Published: (2022)

Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route
by: Trinh Phuong Vo, et al.
Published: (2022)

Comparison of varicella outbreaks in schools in China during different vaccination periods
by: Xiang Sun, et al.
Published: (2022)

Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: An open question
by: Pasquale Stefanizzi, et al.
Published: (2022)

Acceptance of varicella vaccination
by: Andrea Horváth
Published: (2021)

The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka
by: Zuhal Umit, et al.
Published: (2021)

A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)
by: Peter E. Silas, et al.
Published: (2020)

Immunogenicity and safety of inactivated Influenza Split-Virion vaccine administered via a Transdermal Microneedle System
by: Mahmoud Ameri, et al.
Published: (2021)

Global varicella vaccination programs
by: Young Hwa Lee, et al.
Published: (2022)

Stroke as Sequel to Varicella Vaccination
by: J Gordon Millichap
Published: (2005)

Varicella vaccination - the global experience
by: Peter Wutzler, et al.
Published: (2017)

Economic burden of varicella in Europe in the absence of universal varicella vaccination
by: Manjiri Pawaskar, et al.
Published: (2021)

Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019
by: Yuyang Xu, et al.
Published: (2021)

Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study
by: Saul N. Faust, et al.
Published: (2019)

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
by: Valentina Carta, et al.
Published: (2024)

National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysisResearch in context
by: Huangyufei Feng, et al.
Published: (2023)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial
by: Xiaoyu Liu, et al.
Published: (2021)

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
by: Véronique Abitbol, et al.
Published: (2023)

Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults
by: Erin M. Paradis, et al.
Published: (2021)

Safety of an inactivated enterovirus 71 vaccine administered concurrently with other vaccines among infants aged 6-11 months: An observational study using active surveillance
by: Linlin Wu, et al.
Published: (2024)

Vacinas contra varicela e vacina quádrupla viral Varicella vaccines and measles, mumps, rubella, and varicella vaccine
by: Lucia Ferro Bricks, et al.
Published: (2006)

Global impact of varicella vaccination programs
by: Fernanda Hammes Varela, et al.
Published: (2019)

EXPERIENCE OF VACCINE PREVENTION FOR VARICELLA IN YEKATERINBURG
by: O.L. Ksenofontova, et al.
Published: (2010)

EXPERIENCE OF VACCINE PREVENTION FOR VARICELLA IN YEKATERINBURG
by: O.L. Ksenofontova, et al.
Published: (2010)

Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling
by: Jiyeon Suh, et al.
Published: (2022)

A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children
by: Leyla Namazova-Baranova, et al.
Published: (2022)

The impact of varicella vaccination on varicella-related hospitalization rates: global data review
by: Maki Hirose, et al.

Seroepidemiology of varicella in Hangzhou, China in the vaccine era
by: Yuyang Xu, et al.
Published: (2018)

MMR-Varicella Vaccine and Risk of Febrile Seizures
by: J Gordon Millichap
Published: (2010)

THE VACCINATION AGAINST VARICELLA. THE ANSWERS TO THE PEDIATRISTS QUESTIONS
by: V.К. Tatochenko
Published: (2009)

SUBSTANTIATION AND EXPERIENCE OF THE VARICELLA VACCINE USAGE IN VOLGOGRAD
by: L. V. Kramar', et al.
Published: (2012)

THE VACCINATION AGAINST VARICELLA. THE ANSWERS TO THE PEDIATRISTS QUESTIONS
by: V.К. Tatochenko
Published: (2009)

Trends in varicella epidemiology before and after the implementation of universal one-dose varicella vaccination
by: Shih-Wei Lai
Published: (2019)

Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents
by: Erin M. Paradis, et al.
Published: (2021)

Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age
by: Hervé Haas, et al.
Published: (2019)